Blog

Charlie Munger helped build Berkshire Hathaway into a multinational conglomerate. He’s earned his place in the investing hall of fame alongside Warren Buffett. Still, if you have any money in the markets (stocks, bonds, commodities, 401k, etc.)… The motive behind his recent interview could hurt your wealth plan in 2023. Here’s the story:  Munger and […]

History shows investing early in the right companies can be very beneficial.  Take the early days of the tech revolution. On the one hand, you had cautious investors who wanted to wait for more clarification on whether technology was here to stay.  Many missed the boat on some of history's biggest stock market returns. On […]

So here’s a little news from BioTech land…  Summit Technologies is a company that develops drugs to treat infectious diseases. They just struck a licensing deal with a larger company, sending the shares skyrocketing higher. Here’s the chart of SMMT…  You can see they traded sideways pretty much all year until… Wham! That spike you’re […]

Read on for details on this tech company, plus two others with recent “insider purchasing activity” worth checking out. Last week I shared details about three stocks with insider activity worth looking at. I’ve got three more for you today. Let’s start with Rackspace Technology. A cloud computing company based in the suburbs of San […]

Read on to get the details on two other stocks  that have seen recent insider purchasing activity. Stocks with recent insider purchasing are often a ticket to winning investments. I’ve identified three you might want to check out this Cyber Monday. The first is IAC Inc, an American holding company with 150 brands across 100 […]

There’s a reason I’m calling it the “crypto cough”. It’s the latest contagion to get out into the wild… And if what we’re seeing so far is any indication, this thing is seriously spreadable. With the biggest risk of spill over being to tech stocks. Today, we’ve got another development, this time with a company […]

If you’ve been following my musings this year, you probably already know that I’m bullish on BioTechs over the next few years. They’re not ridiculously overpriced, the companies aren’t dependent on impossibly cheap money to fund themselves, and institutions love ‘em. That means that if they get favorable news from a good trial… a tsunami […]

I call this the Horror Movie Sequel Setup because it reminds me of what happens in popular slasher flicks. Like just when you think that Freddy Kruger, Jason Vorhees, or Michael Myers are dead and the world is safe once again… There’s a little hint at the end of the movie that tells you “not […]